Publications by authors named "Naoko Unami"

Claim this Profile
A
Anticoagulant activity of apixaban can be estimated by multiple regression analysis.
Naoko Unami, Yuya Ise, Hidenori Suzuki

J Arrhythm· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6.
Kouji Hattori, Masaya Orita, Susumu Toda, Masashi Imanishi, Shinji Itou, Naoko Unami

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: part 5.
Kouji Hattori, Susumu Toda, Masashi Imanishi, Shinji Itou, Yutaka Nakajima, Naoko Unami

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
Yutaka Nakajima, Masashi Imanishi, Shinji Itou, Hitoshi Hamashima, Yasuyo Tomishima, Naoko Unami

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of benzoic acid derivatives as potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety.
Masashi Imanishi, Yutaka Nakajima, Yasuyo Tomishima, Hitoshi Hamashima, Kenichi Washizuka, Naoko Unami

J Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part II.
Masashi Imanishi, Shinji Itou, Kenichi Washizuka, Hitoshi Hamashima, Yutaka Nakajima, Naoko Unami

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
Masashi Imanishi, Yasuyo Tomishima, Shinji Itou, Hitoshi Hamashima, Yutaka Nakajima, Naoko Unami

J Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis